Organisation › Details

Boehringer Ingelheim (Group)

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 143 affiliates in 47 countries and almost 37,500 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.
In 2005, Boehringer Ingelheim posted net sales of 9.5 billion euro while spending almost one fifth of net sales in its largest business segment Prescription Medicines on research and development. *

 

Period Start 1885-01-01 established
Product Industry pharmaceutical
Persons Person Boehringer, Christian (Boehringer 201207 Chairman of Shareholders’ Committee)
  Person 2 Barner, Andreas (Boehringer)
     
Region Region Ingelheim
  Country Germany
  Street 173 Binger Str.
  City 55216 Ingelheim
  Tel +49-6132-770
    Address record changed: 2018-07-24
     
Basic data Employees I: 50,001 to 100,0 (2016-12-31)
  Currency EUR
  Annual sales 17,498,000,000 (sales, net, consolidated (2018) 2018-12-31)
  Profit 2,075,000,000 (2018-12-31)
  Cash 4,303,000,000 (2018-12-31)
     
    * Document for �About Section�: 
     
   
Record changed: 2019-09-10

Advertisement

[iito] Business Intelligence – The Elephants Are Coming 560x91px

More documents for Boehringer Ingelheim (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture [iito] – Putting Information into Context 600x60px




» top